cancer

The journal Science published an article last month that garnered far more attention than usually. In it, the authors made a provocative claim: two-thirds of the variation of cancer risk among different types of tissues can be attributed to random mutations, in other words, “bad luck.”

Researchers at the University of British Columbia are leading the first nationwide project on how sexual and gender minorities experience cancer, highlighting previously overlooked communities’ perspectives on cancer care.

The stress of scheduling chemotherapy treatments has been substantially reduced by a new technology created and implemented by a team of researchers from the Sauder School of Business at the University of British Columbia and the BC Cancer Agency.

A team of researchers from the University of British Columbia, BC Cancer Agency and Vancouver Coastal Health Research Institute has received a $3.1-million grant from Terry Fox Foundation to study genetic aspects of rare cancers.

Together with TRIUMF and other partners, the BC Cancer Agency (BCCA) has received a $1.3-million grant from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to develop an alternative source of medical isotopes. The BC grant is the largest out of seven nationally funded projects.

Prof. Sam Aparicio of Pathology and Laboratory Medicine and Canada Research Chair in Molecular Oncology, and Prof. of Medical Genetics Marco Marra, create landmark genome that illuminates cancer development and offers new hope for fighting the disease.